Autoimmune And Rheumatic Diseases

Jonas Salk said, “The mind, in addition to medicine, has powers to turn the immune system around.”

There is no doubt that patients with rheumatic and autoimmune diseases are taking full advantage of relaxed laws in the United States surrounding recreational cannabis use.

Patients with PTSD demonstrated a two-fold higher likelihood of being diagnosed with systemic lupus erythematosus, compared to those without PTSD, according to data published in Arthritis Care & Research.

The American College of Rheumatology has updated its COVID-19 vaccine clinical guidance for patients with rheumatic diseases to recommend a third dose of the mRNA vaccine in those receiving immunosuppressive or immunomodulatory therapy.

The spectrum of conditions under the amyloidosis umbrella can present in myriad ways in patients with rheumatic diseases, with several possible complications, according to data from the 2021 Congress of Clinical Rheumatology-East.

More thorough understanding of giant cell arteritis disease processes has shed light on how immune checkpoint inhibitors may be exacerbating this and other immune-mediated conditions, according to a presenter here.

Approximately 27% of patients with a rheumatic disease experienced a change in employment status during the early months of the COVID-19 pandemic, according to survey results published in The Lancet Rheumatology.

In a new editorial, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, talks about issues that rheumatologists face in the era of COVID-19.

Like so many rheumatology meetings over the last year and a half, the 2021 Congress of Clinical Rheumatology – East has adapted to suit the rolling waves of the pandemic.

Approximately 18% of patients in a rheumatic disease registry used cannabis in 2019, up from 6.3% in 2014, with the highest prevalence occurring in states where its use is legal, according to data published in Arthritis Care & Research.